NCT00218517View on ClinicalTrials.gov

Effectiveness of Selegiline in Treating Marijuana Dependent Individuals - 1

PHASE2CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions
Marijuana Abuse
Interventions
DRUG

Selegiline hydrochloride

Daily oral selegiline, 5 mg po qd x 7 days, then 5 mg po bid for 7 weeks

DRUG

Placebo

Matching placebo capsules using blue 00 capsules

Trial Locations (1)

06519

MRU, New Haven

All Listed Sponsors
lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00218517 - Effectiveness of Selegiline in Treating Marijuana Dependent Individuals - 1 | Biotech Hunter | Biotech Hunter